Special Issue "Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer 2019"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 August 2019) | Viewed by 45052
Interests: biomarkers of prostate cancer; artificial neural networks; prostate health index
Special Issues, Collections and Topics in MDPI journals
Interests: clinical biochemistry; molecular and biochemical urooncology; RNA and DNA biology; general laboratory medicine
Prostate cancer is the most common cancer in men in the Western world. Therefore, its early diagnosis, which is mainly based on serum prostate-specific antigen (PSA), has especially gained attention in several fields of research. New biomarkers in serum and urine have been described; for example, the prostate health index (PHI) or urinary Prostate cancer gene 3 (PCA3), or others, including several biomarker-based multivariate models. However, not only the diagnosis, but also, more so, the prognosis or further prediction of this very common disease is important to know. Here, several new nucleic acid or protein-based tissue biomarkers have been described. As already described for other types of cancer, individualized medicine, such as theranostics, a combination of diagnostics and therapeutics, has been a new attraction for late stage prostate cancer, including castration resistant prostate cancer. This Special Issue focuses on “Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer”.
We warmly welcome submissions, including original papers and reviews, on this widely-discussed topic.
Prof. Carsten Stephan
Prof. Klaus Jung
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Urinary biomarkers on prostate cancer
- Serum/plasma biomarkers
- Tissue biomarkers (nuleic acid/protein-based)
- Prognostic factors
- Multivariate models